1. DeCamp WH (2001) The impact of polymorphism on drug development: a regulator’s viewpoint. Am Pharm Rev 4:75–77
2. Byrn SR, Pfeiffer RR, Stowell JG (2002) Polymorphs, regulations, crystallization, and solid-state chemistry. Am Pharm Rev 5:96–99
3. Storey RA, Docherty R, Higginson PD (2003) Integration of high throughput screening methodologies and manual processes for solid form selection. Am Pharm Rev 6:104–105
4. Ticehurst M, Docherty R (2006) From molecules to pharmaceutical products – the drug substance/drug product interface. Am Pharm Rev 9:34–36
5. Sun CC (2009) Materials science tetrahedron – a useful tool for pharmaceutical research and development. J Pharm Sci 98:1671–1687